Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
CVRx, Inc.CVRX-5.797.175.11-5.72-79.02%-46.45%63.23$12.89$85.515,028$14.864

Detail of CVRx, Inc.

 
CEO
Mr. Nadim Yared
Employees
109
Industry
Medical Devices
Sector
Healthcare
Market cap
$339M

Company details

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$47.26M
Cost of goods (CoG)
-$7.48M
Gross profit (GP)
$39.77M
Operating expense (OE)
-$98.65M
Research and development (R&D)
-$10.57M
General and administrative (G&A)
-$88.08M
Operating income (OI)
-$58.88M
Other income expense (OIE)
-$4.02M
Pretax income (PI)
-$58.31M
Tax (TAX)
-$165,000.00
Net income (NI)
-$58.48M
CVRx, Inc.
CVRX • XNGS • US
$14.864
-9.40 (-38.73%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$2.57
Margin profit
-123.75%
52 week low
$6.49
52 week high
$33.029999
50-day simple moving average
$13.95
200-day simple moving average
$12.89
Percent held by insiders
4.40%
Percent held by institutions
71.94%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
CVRX -38.81%
eps change
CVRX 0.00%